
Nov 25 (Reuters) - Allurion Technologies Inc ALUR.N:
ALLURION ANNOUNCES INITIAL RESULTS ON COMBINING THE ALLURION PROGRAM WITH LOW-DOSE TIRZEPATIDE TO OPTIMIZE MUSCLE MASS AND GLP-1 ADHERENCE
ALLURION TECHNOLOGIES INC - AVERAGE WEIGHT LOSS OF 23% WITH 14% INCREASE IN LEAN BODY MASS